Effect of Phospholipase Inhibitor Okadaic Acid on HBV Replication in HepG2.2.15 Cells
PAN Xiao-ben,JI Ying,ZHU Ling,WANG Qian,GUAN Wen-li,HAN Jin-chao,WEI Lai
DOI: https://doi.org/10.3969/j.issn.1673-713x.2007.06.002
2007-01-01
Abstract:Objective To identify the phospholipase involved in the dephosphorylation of core protein in HBV life cycle. Methods Human hepatocarcinoma cell line HepG2.2.15 was divided into 4 groups, and respectively treated with 0, 10, 20, or 30 ng/ml okadaic acid (OA) as the control, OA 10 ng, OA 20 ng, and OA 30 ng groups (5 wells in each group). Then the cells culture supernate was collected on days 0, 2, 4, and 6. The concentrations of HBsAg and HBV DNA in the cells culture supernate were determined by electrochemiluminescence and real-time fluorescence PCR, respectively. The heterogeneity and subcellular distribution of HBcAg in the cells collected on day 2 was detected by fluorescence immunocytochemistry and western blot. Results At any time point, no significant difference was observed between the OA 10 ng and OA 20 ng groups and the control in the concentrations of HBsAg and HBV DNA, as well as in the heterogeneity and subcellular distribution of HBcAg on day 2. Whereas, in the OA 30 ng group, the concentration of HBsAg (ng/ml) was significantly lower than that in the control on days 2, 4 and 6 [(385.9 ± 43.1) vs (510.2 ± 63.3), P = 0.028; (346.5 ± 39.6) vs (484.6 ± 59.4), P = 0.022; and (295.1 ± 32.8) vs (467.2 ± 52.9), P = 0.016]. On day 2, the concentration of HBV DNA (ml-1) in the OA 30 ng group was significantly higher than that in the control [(6.71 ± 6.07) vs (6.34 ± 5.72), P = 0.022], while on days 4 and 6, it was significantly lower [(5.80 ± 5.19) vs (6.29 ± 5.68) and (4.75 ± 4.15) vs (6.25 ± 5.58), P = 0.008 and 0.005, respectively). In the OA 30 ng group, band broadening in electrophoresis was observed on day 2, meanwhile the intensity of HBcAg red signals in the nuclei was markedly increased in approximately 20% of the HepG2.2.15 cells.Conclusions Short-term and high-concentration OA treatment can increase the levels of HBV DNA replication and core protein phosphorylation in HepG2.2.15 cells. Phospholipase 2A may play a role in core protein dephosphorylation during HBV life cycle.